Raplixa FDA Approval History
FDA Approved: Yes (First approved April 30, 2015)
Brand name: Raplixa
Generic name: fibrin sealant [human]
Company: The Medicines Company
Treatment for: Hemostasis
Raplixa (fibrin sealant [human]) is a spray-dried fibrin sealant used to help control bleeding during surgery.
Development timeline for Raplixa
| Date | Article |
|---|---|
| Apr 30, 2015 | Approval FDA Approves Raplixa (fibrin sealant [human]) to Control Bleeding During Surgery |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.